Juyoung Yoo1, Sung Soo Ahn1, Seung Min Jung1, Jason Jungsik Song1,2, Yong-Beom Park1,2, Sang-Won Lee3,4. 1. Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, South Korea. 2. Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, South Korea. 3. Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, South Korea. sangwonlee@yuhs.ac. 4. Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, South Korea. sangwonlee@yuhs.ac.
Abstract
OBJECTIVES: We investigated whether elevated serum IgG4 at the time of diagnosis of microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) may be associated with concurrent IgG4-related disease (IgG4-RD) in immunosuppressive drug-naïve patients. METHODS: We retrospectively reviewed the medical records of 46 MPA and GPA patients with results on serum IgG4 and histology at diagnosis. Elevated serum IgG4 was defined as IgG4 > 135 mg/dL. We collected clinical and laboratory data at diagnosis including ANCA, white blood cell (WBC) count, haemoglobin, platelet, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and serum IgG4, and calculated Birmingham vasculitis activity score (BVAS) at diagnosis. We compared variables between patients with MPA and GPA and assessed the correlation of serum IgG4 and other continuous variables. RESULTS: Twenty-eight patients (60.9%) were classified as MPA and 18 patients (39.1%) as GPA. The mean age at diagnosis was 61.0 years and 17 patients (37.0%) were men. The serum IgG4 at diagnosis was 1202.7 mg/dL and 37 patients (80.4%) had elevated serum IgG4 at diagnosis. We found no patients, who could be classified as IgG4-RD according to comprehensive diagnostic criteria for IgG4-RD among 46 patients. The mean serum IgG at diagnosis was not different between the two groups. Serum IgG4 was significantly correlated with inflammation-related variables at diagnosis including BVAS (r = 0.367), platelet (r = 0.398), ESR (r = 0.327), and CRP (r = 0.373). CONCLUSIONS: Elevated serum IgG4 is not associated with concurrent IgG4-RD, and it may reflect activity and inflammatory burden of vasculitis in patients with MPA and GPA at diagnosis.
OBJECTIVES: We investigated whether elevated serum IgG4 at the time of diagnosis of microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) may be associated with concurrent IgG4-related disease (IgG4-RD) in immunosuppressive drug-naïve patients. METHODS: We retrospectively reviewed the medical records of 46 MPA and GPA patients with results on serum IgG4 and histology at diagnosis. Elevated serum IgG4 was defined as IgG4 > 135 mg/dL. We collected clinical and laboratory data at diagnosis including ANCA, white blood cell (WBC) count, haemoglobin, platelet, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and serum IgG4, and calculated Birmingham vasculitis activity score (BVAS) at diagnosis. We compared variables between patients with MPA and GPA and assessed the correlation of serum IgG4 and other continuous variables. RESULTS: Twenty-eight patients (60.9%) were classified as MPA and 18 patients (39.1%) as GPA. The mean age at diagnosis was 61.0 years and 17 patients (37.0%) were men. The serum IgG4 at diagnosis was 1202.7 mg/dL and 37 patients (80.4%) had elevated serum IgG4 at diagnosis. We found no patients, who could be classified as IgG4-RD according to comprehensive diagnostic criteria for IgG4-RD among 46 patients. The mean serum IgG at diagnosis was not different between the two groups. Serum IgG4 was significantly correlated with inflammation-related variables at diagnosis including BVAS (r = 0.367), platelet (r = 0.398), ESR (r = 0.327), and CRP (r = 0.373). CONCLUSIONS: Elevated serum IgG4 is not associated with concurrent IgG4-RD, and it may reflect activity and inflammatory burden of vasculitis in patients with MPA and GPA at diagnosis.
Entities:
Keywords:
Granulomatosis with polyangiitis; IgG4-related disease; Microscopic polyangiitis
Authors: John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks Journal: N Engl J Med Date: 2010-07-15 Impact factor: 91.245
Authors: Sing Yun Chang; Karina A Keogh; Jean E Lewis; Jay H Ryu; Lynn D Cornell; James A Garrity; Eunhee S Yi Journal: Hum Pathol Date: 2013-08-30 Impact factor: 3.466
Authors: Vikram Deshpande; Yoh Zen; John Kc Chan; Eunhee E Yi; Yasuharu Sato; Tadashi Yoshino; Günter Klöppel; J Godfrey Heathcote; Arezou Khosroshahi; Judith A Ferry; Rob C Aalberse; Donald B Bloch; William R Brugge; Adrian C Bateman; Mollie N Carruthers; Suresh T Chari; Wah Cheuk; Lynn D Cornell; Carlos Fernandez-Del Castillo; David G Forcione; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Gregory Y Lauwers; Yasufumi Masaki; Yasuni Nakanuma; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant V Sahani; Thomas C Smyrk; James R Stone; Masayuki Takahira; George J Webster; Motohisa Yamamoto; Giuseppe Zamboni; Hisanori Umehara; John H Stone Journal: Mod Pathol Date: 2012-05-18 Impact factor: 7.842
Authors: A Khosroshahi; Z S Wallace; J L Crowe; T Akamizu; A Azumi; M N Carruthers; S T Chari; E Della-Torre; L Frulloni; H Goto; P A Hart; T Kamisawa; S Kawa; M Kawano; M H Kim; Y Kodama; K Kubota; M M Lerch; M Löhr; Y Masaki; S Matsui; T Mimori; S Nakamura; T Nakazawa; H Ohara; K Okazaki; J H Ryu; T Saeki; N Schleinitz; A Shimatsu; T Shimosegawa; H Takahashi; M Takahira; A Tanaka; M Topazian; H Umehara; G J Webster; T E Witzig; M Yamamoto; W Zhang; T Chiba; J H Stone Journal: Arthritis Rheumatol Date: 2015-07 Impact factor: 10.995
Authors: Shaun A Summers; Oliver M Steinmetz; Poh-Yi Gan; Joshua D Ooi; Dragana Odobasic; A Richard Kitching; Stephen R Holdsworth Journal: Arthritis Rheum Date: 2011-04
Authors: Loïc Guillevin; Christian Pagnoux; Alexandre Karras; Chahera Khouatra; Olivier Aumaître; Pascal Cohen; François Maurier; Olivier Decaux; Jacques Ninet; Pierre Gobert; Thomas Quémeneur; Claire Blanchard-Delaunay; Pascal Godmer; Xavier Puéchal; Pierre-Louis Carron; Pierre-Yves Hatron; Nicolas Limal; Mohamed Hamidou; Maize Ducret; Eric Daugas; Thomas Papo; Bernard Bonnotte; Alfred Mahr; Philippe Ravaud; Luc Mouthon Journal: N Engl J Med Date: 2014-11-06 Impact factor: 91.245
Authors: Abdullah Hussain; Tanya Pankhurst; Margaret Goodall; Rachel Colman; Royston Jefferis; Caroline O S Savage; Julie M Williams Journal: Immunology Date: 2009-10 Impact factor: 7.397
Authors: Riccardo Capecchi; Domenico Giannese; Diego Moriconi; Angelo G Bonadio; Federico Pratesi; Cristina Croia; Maria F Egidi; Ilaria Puxeddu; Antonio G Tavoni; Paola Migliorini Journal: Front Med (Lausanne) Date: 2021-03-31
Authors: Verena Endmayr; Cansu Tunc; Lara Ergin; Anna De Rosa; Rosa Weng; Lukas Wagner; Thin-Yau Yu; Andreas Fichtenbaum; Thomas Perkmann; Helmuth Haslacher; Nicolas Kozakowski; Carmen Schwaiger; Gerda Ricken; Simon Hametner; Sigrid Klotz; Lívia Almeida Dutra; Christian Lechner; Désirée de Simoni; Kai-Nicolas Poppert; Georg Johannes Müller; Susanne Pirker; Walter Pirker; Aleksandra Angelovski; Matus Valach; Michelangelo Maestri; Melania Guida; Roberta Ricciardi; Florian Frommlet; Daniela Sieghart; Miklos Pinter; Karl Kircher; Gottfried Artacker; Romana Höftberger; Inga Koneczny Journal: Front Immunol Date: 2022-01-14 Impact factor: 7.561
Authors: David Faz-Muñoz; Andrea Hinojosa-Azaola; Juan M Mejía-Vilet; Norma O Uribe-Uribe; Marina Rull-Gabayet; Wallace Rafael Muñoz-Castañeda; Nancy Janeth Vargas-Parra; Eduardo Martín-Nares Journal: Immunol Res Date: 2022-04-21 Impact factor: 4.505